Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 12, 2023First-in-class ALTUVIIIO offers clinically proven highly effective bleed protection with once-weekly dosing for children with hemophilia A
-
Aug 24, 2023The recommendation helps to ensure all infants have the opportunity to be protected from RSV disease ahead of the next winter virus season
-
May 5, 202317 abstracts showcase new data for Dupixent, itepekimab and anti-IL-13/TSLP NANOBODY® molecule in COPD and asthma
-
Apr 27, 2023
-
Mar 23, 2023First and only biologic to demonstrate clinically meaningful and statistically significant reduction (30%) in exacerbations compared to placebo
-
Mar 18, 2023More than twice as many patients on Dupixent achieved clear or almost clear skin compared to placebo at 16 weeks